A rare, in-depth study of a woman who lived past her 117th birthday suggests that extreme longevity is not simply the absence of aging. Instead, it may involve intense biological aging running alongside unusually strong protective mechanisms, according to researchers who examined multiple layers of her biology.
Maria Branyas, who died at 117, became the subject of one of the most detailed investigations ever conducted on a supercentenarian. Scientists found evidence of advanced aging in some systems, but also discovered low inflammation, beneficial gut bacteria, protective genetic features, and a biological age that was younger than her actual age. Because she avoided major disease for nearly all of her life, the study offered a rare window into the aging process itself, rather than the illnesses that typically accompany it.
The findings challenge a common assumption that living to extreme old age means escaping the biological wear and tear of time. In Branyas, researchers observed signs of significant aging, yet her body also displayed molecular and microbial characteristics often associated with youth and resilience. The combination suggests that longevity may depend on a delicate balance between damage and defense, rather than the simple slowing of one process.
Low inflammation stood out as a key feature. Chronic, low-grade inflammation — sometimes called inflammaging — is widely linked to frailty, heart disease, and cognitive decline in older adults. Branyas showed unusually low levels, which may have helped protect her tissues and organs from the cumulative damage that normally accumulates with age.
Her gut microbiome also drew attention. Beneficial bacteria in the digestive tract can influence immune function, metabolism, and even neurological health. The study indicates that her microbial community may have contributed to her ability to avoid serious illness, though researchers caution that the exact role of gut bacteria in extreme longevity remains an active area of investigation.
Genetic analysis revealed protective features that could help explain her exceptional health span. Certain gene variants may enhance cellular repair, regulate inflammation, or improve how the body handles stress and damage. At the same time, her biological age — measured through molecular markers rather than birthdays — was younger than her chronological age, suggesting that some aspects of her physiology remained more youthful than expected.
The case is significant because supercentenarians are exceedingly rare, and most studies of aging focus on people who already have age-related diseases. By examining someone who reached 117 without major illness, the researchers could isolate aging from disease, at least partially. That distinction matters for developing interventions that target the aging process itself rather than one condition at a time.
Still, a single case cannot establish cause and effect. Branyas may have possessed a unique combination of genetics, lifestyle, and environmental factors that cannot be generalized to the wider population. The researchers emphasize that more work is needed to determine which of these features are shared by other extremely long-lived individuals and which are personal quirks.
What the study does provide is a detailed map of one extraordinary life at the biological level. It shows that extreme old age can coexist with signs of advanced aging, and that protection against disease may come from multiple systems working together — immune regulation, microbial balance, and genetic safeguards. For scientists trying to understand how to extend healthy years, that complexity is both a challenge and a clue.
The findings add to a growing body of research suggesting that aging is not a single uniform process. Different organs and systems can age at different rates, and the interplay between them may determine whether a person remains healthy or becomes frail. Branyas, in her 117 years, appears to have carried both the marks of time and an unusual capacity to resist its worst effects.
